Fact CheckerSign in

NCT06817655Not yet recruiting

The Research of French PaRole OncO : A Peer Supported Program for Cancer Patients

Implementation and Evaluation of Peer Support in Oncology in France : a Multisite Participatory Action Research - Adaptation and Transfer in France of the Quebec PAROLE ONCO Research Program

Source: ClinicalTrials.gov · Last updated 10 Feb 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Peer support is a valuable mode of accompaniment between individuals who are facing or have faced similar challenging life experiences. In this context, a patient advisor (PA) shares their experiential knowledge, derived from living with a disease, to offer emotional, experiential, and informational support to other patients. This PA intervention represents an innovative form of support for oncology patients, potentially addressing their needs more comprehensively throughout the care pathway by integrating psychosocial dimensions into the support approach. The present pilot study aims to investigate the implementation and effectiveness of the peer-to-peer support program "PaRole OncO France" in the oncology setting. The study will focus on: 1. Evaluating clinical and psychosocial parameters 2. Utilizing an in-depth multiple case study approach This research seeks to provide insights into how peer support can enhance the overall care experience for oncology patients, potentially leading to improved patient outcomes and a more holistic approach to cancer care.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
720 (estimated)
First submitted
29 Jan 2025
Start date
15 Mar 2025
Primary completion date
15 Jun 2027
Lead sponsor
Hospices Civils de Lyon
NCT number
NCT06817655

What you commit to

  • Study type: Interventional
  • Planned participants: 720
  • From 15 Mar 2025 to the primary completion date, 15 Jun 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patient advisors :
    • Recurrence of the disease
    • Currently undergoing treatment for active cancer

Other

  • Patients participants :
    • Not followed in one of the participating units
    • Persons deprived of their liberty by judicial or administrative decision
    • Persons not affiliated to a social security scheme or beneficiaries of a similar scheme

Who the study is looking for

  • Patient participants :
    • Patients with newly diagnosed or recurrent cancer (urological, digestive, mammary, pulmonary, ORL, peritoneal carcinosis, melanoma, oncohaematology)
    • French-speaking patients
  • Patients adivsors :
    • Patient advisors will be past cancer patients not currently undergoing treatment for their cancer, and considered without evidence of disease
    • French-speaking patients

Age in the registry: 15 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hospices Civils de Lyon
Coordinator of this site? Confirm its status
LyonFranceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.